αC helix displacement as a general approach for allosteric modulation of protein kinases

L Palmieri, G Rastelli - Drug Discovery Today, 2013 - Elsevier
Owing to their crucial role in the modulation of cell pathways, protein kinases are important
targets for several human diseases, including but not limited to cancer. The classic approach …

Tinkering outside the kinase ATP box: allosteric (type IV) and bivalent (type V) inhibitors of protein kinases

KJ Cox, CD Shomin, I Ghosh - Future medicinal chemistry, 2011 - Future Science
Many members of the protein kinase family have emerged as key targets for
pharmacological intervention, most notably in cancer. However, the high sequence and …

Allosteric small-molecule serine/threonine kinase inhibitors

RC Panicker, S Chattopadhaya, AG Coyne… - Protein Allostery in Drug …, 2019 - Springer
Deregulation of protein kinase activity has been linked to many diseases ranging from
cancer to AIDS and neurodegenerative diseases. Not surprisingly, drugging the human …

Strategies for the selective regulation of kinases with allosteric modulators: exploiting exclusive structural features

Z Fang, C Grütter, D Rauh - ACS chemical biology, 2013 - ACS Publications
The modulation of kinase function has become an important goal in modern drug discovery
and chemical biology research. In cancer-targeted therapies, kinase inhibitors have been …

Divergent modulation of Src-family kinase regulatory interactions with ATP-competitive inhibitors

SE Leonard, AC Register, R Krishnamurty… - ACS Chemical …, 2014 - ACS Publications
Multidomain protein kinases, central controllers of signal transduction, use regulatory
domains to modulate catalytic activity in a complex cellular environment. Additionally, these …

Human kinome drug discovery and the emerging importance of atypical allosteric inhibitors

RM Eglen, T Reisine - Expert Opinion on Drug Discovery, 2010 - Taylor & Francis
Importance of the field: Protein kinases are important targets for drug discovery because
they possess critical roles in many human diseases. Several protein kinase inhibitors have …

New directions in targeting protein kinases: focusing upon true allosteric and bivalent inhibitors

V Lamba, I Ghosh - Current pharmaceutical design, 2012 - ingentaconnect.com
Over the past decade, therapeutics that target subsets of the 518 human protein kinases
have played a vital role in the fight against cancer. Protein kinases are typically targeted at …

Renaissance of allostery to disrupt protein kinase interactions

AE Leroux, RM Biondi - Trends in Biochemical Sciences, 2020 - cell.com
Protein–protein interactions often regulate the activity of protein kinases by allosterically
modulating the conformation of the ATP-binding site. Bidirectional allostery implies that …

Targeting the unactivated conformations of protein kinases for small molecule drug discovery

GR Alton, EA Lunney - Expert Opinion on Drug Discovery, 2008 - Taylor & Francis
Background: The number of drugs in active clinical development or on the market that target
the unactivated conformational states of protein kinases is growing and represents a …

Novel approaches for targeting kinases: allosteric inhibition, allosteric activation and pseudokinases

SW Cowan-Jacob, W Jahnke, S Knapp - Future medicinal chemistry, 2014 - Future Science
Protein kinases are involved in many essential cellular processes and their deregulation can
lead to a variety of diseases, including cancer. The pharmaceutical industry has invested …